These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9665952)

  • 1. A modified enzyme-linked immunosorbent assay for measurement of antibody responses to meningococcal C polysaccharide that correlate with bactericidal responses.
    Granoff DM; Maslanka SE; Carlone GM; Plikaytis BD; Santos GF; Mokatrin A; Raff HV
    Clin Diagn Lab Immunol; 1998 Jul; 5(4):479-85. PubMed ID: 9665952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial.
    MacDonald NE; Halperin SA; Law BJ; Forrest B; Danzig LE; Granoff DM
    JAMA; 1998 Nov; 280(19):1685-9. PubMed ID: 9832000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine.
    Vermont CL; van Dijken HH; van Limpt CJ; de Groot R; van Alphen L; van Den Dobbelsteen GP
    Infect Immun; 2002 Feb; 70(2):584-90. PubMed ID: 11796586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between serum bactericidal activity and serogroup-specific immunoglobulin G concentration for adults, toddlers, and infants immunized with Neisseria meningitidis serogroup C vaccines.
    Sikkema DJ; Friedman KE; Corsaro B; Kimura A; Hildreth SW; Madore DV; Quataert SA
    Clin Diagn Lab Immunol; 2000 Sep; 7(5):764-8. PubMed ID: 10973451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents.
    Zhang Q; Choo S; Everard J; Jennings R; Finn A
    Infect Immun; 2000 May; 68(5):2692-7. PubMed ID: 10768961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial.
    Lieberman JM; Chiu SS; Wong VK; Partidge S; Chang SJ; Chiu CY; Gheesling LL; Carlone GM; Ward JI
    JAMA; 1996 May; 275(19):1499-503. PubMed ID: 8622225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-dependent Neisseria meningitidis serogroup C class-specific antibody concentrations and bactericidal titers in sera from young children from Montana immunized with a licensed polysaccharide vaccine.
    Maslanka SE; Tappero JW; Plikaytis BD; Brumberg RS; Dykes JK; Gheesling LL; Donaldson KB; Schuchat A; Pullman J; Jones M; Bushmaker J; Carlone GM
    Infect Immun; 1998 Jun; 66(6):2453-9. PubMed ID: 9596702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide--CRM197 with a meningococcal group C conjugate vaccine in healthy infants: challenge phase.
    Riddell A; Buttery JP; McVernon J; Chantler T; Lane L; Bowen-Morris J; Diggle L; Morris R; Lockhart S; Pollard AJ; Cartwright K; Moxon ER
    Vaccine; 2007 May; 25(19):3906-12. PubMed ID: 17368663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary and booster mucosal immune responses to meningococcal group A and C conjugate and polysaccharide vaccines administered to university students in the United Kingdom.
    Zhang Q; Lakshman R; Burkinshaw R; Choo S; Everard J; Akhtar S; Finn A
    Infect Immun; 2001 Jul; 69(7):4337-41. PubMed ID: 11401971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avidity of IgG antibodies against meningococcal serogroup a polysaccharide and correlations with bactericidal activity in sera from meningitis patients and controls from Ethiopia.
    Medhane M; Tunheim G; Naess LM; Mihret W; Bedru A; Norheim G; Petros B; Aseffa A; Rosenqvist E
    Scand J Immunol; 2014 Apr; 79(4):267-75. PubMed ID: 24383864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults.
    Anderson EL; Bowers T; Mink CM; Kennedy DJ; Belshe RB; Harakeh H; Pais L; Holder P; Carlone GM
    Infect Immun; 1994 Aug; 62(8):3391-5. PubMed ID: 8039909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody responses to the capsular polysaccharide of Neisseria meningitidis serogroup B in patients with meningococcal disease.
    Granoff DM; Kelsey SK; Bijlmer HA; Van Alphen L; Dankert J; Mandrell RE; Azmi FH; Scholten RJ
    Clin Diagn Lab Immunol; 1995 Sep; 2(5):574-82. PubMed ID: 8548537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Modified ELISA for Measurement of High-Avidity IgG Antibodies to Meningococcal Serogroup C Polysaccharide that Correlate with Bactericidal Titers.
    Granoff DM; Donnelly JJ
    Methods Mol Med; 2001; 66():305-15. PubMed ID: 21336763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial.
    MacLennan JM; Shackley F; Heath PT; Deeks JJ; Flamank C; Herbert M; Griffiths H; Hatzmann E; Goilav C; Moxon ER
    JAMA; 2000 Jun; 283(21):2795-801. PubMed ID: 10838647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningococcal serogroup C-specific IgG antibody responses and serum bactericidal titres in children following vaccination with a meningococcal A/C polysaccharide vaccine.
    Borrow R; Richmond P; Kaczmarski EB; Iverson A; Martin SL; Findlow J; Acuna M; Longworth E; O'Connor R; Paul J; Miller E
    FEMS Immunol Med Microbiol; 2000 May; 28(1):79-85. PubMed ID: 10767611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of meningococcus serogroup C conjugate vaccine administered as a primary or booster vaccination to healthy four-year-old children.
    McVernon J; Maclennan J; Buttery J; Oster P; Danzig L; Moxon ER
    Pediatr Infect Dis J; 2002 Aug; 21(8):747-53. PubMed ID: 12192163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune memory in children previously vaccinated with an experimental quadrivalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine.
    Pichichero M; Papa T; Blatter M; Mitchell D; Kratz R; Sneed J; Bassily E; Casey J; Gilmet G
    Pediatr Infect Dis J; 2006 Nov; 25(11):995-1000. PubMed ID: 17072120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody responses to serogroup B meningococcal outer membrane antigens after vaccination and infection.
    Rosenqvist E; Harthug S; Frøholm LO; Høiby EA; Bøvre K; Zollinger WD
    J Clin Microbiol; 1988 Aug; 26(8):1543-8. PubMed ID: 3139705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.
    Robertson CA; Greenberg DP; Hedrick J; Pichichero M; Decker MD; Saunders M
    Vaccine; 2016 Oct; 34(44):5273-5278. PubMed ID: 27642132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison on the levels of human serum antibody against Neisseria meningitidis serogroup C measured using serum bactericidal assay and ELISA].
    Zhu BQ; Xu L; Zhou HJ; Shao ZJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 May; 33(5):521-4. PubMed ID: 22883183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.